These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36980320)

  • 21. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
    Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship Between FDG Uptake and Neutrophil/Lymphocyte Ratio in Patients with Invasive Ductal Breast Cancer.
    Fujii T; Yanai K; Tokuda S; Nakazawa Y; Kurozumi S; Obayashi S; Yajima R; Hirakata T; Shirabe K
    Anticancer Res; 2018 Aug; 38(8):4927-4931. PubMed ID: 30061271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy.
    Hirahara N; Matsubara T; Mizota Y; Ishibashi S; Tajima Y
    BMC Surg; 2016 Sep; 16(1):66. PubMed ID: 27650456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative lymphocyte-monocyte ratio is not an independent prognostic factor in M0 (stage I-III) esophageal squamous cell carcinomas.
    Chen C; Chen G; Wu Y; Li J
    Transl Cancer Res; 2020 May; 9(5):3483-3490. PubMed ID: 35117713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining PD-L1 Expression and Standardized Uptake Values in FDG-PET/CT Can Predict Prognosis in Patients With Resectable Non-Small-Cell Lung Cancer.
    Miyazawa T; Otsubo K; Sakai H; Kimura H; Chosokabe M; Morikawa K; Furuya N; Marushima H; Kojima K; Mineshita M; Koike J; Saji H
    Cancer Control; 2021; 28():10732748211038314. PubMed ID: 34384268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and prognostic significance of preoperative lymphocyte-monocyte ratio, neutrophil-lymphocyte ratio and neutrophil-monocyte ratio on esophageal squamous cell carcinoma patients.
    Shang QX; Yang YS; Hu WP; Yuan Y; He Y; Zhao JY; Ji AF; Chen LQ
    Transl Cancer Res; 2020 Jun; 9(6):3903-3914. PubMed ID: 35117757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer.
    Kaira K; Serizawa M; Koh Y; Takahashi T; Yamaguchi A; Hanaoka H; Oriuchi N; Endo M; Ohde Y; Nakajima T; Yamamoto N
    Lung Cancer; 2014 Feb; 83(2):197-204. PubMed ID: 24365102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorodeoxyglucose uptake is associated with low tumor-infiltrating lymphocyte levels in patients with small cell lung cancer.
    Kasahara N; Kaira K; Yamaguchi K; Masubuchi H; Tsurumaki H; Hara K; Koga Y; Sakurai R; Higuchi T; Handa T; Oyama T; Yokobori T; Shimizu K; Asao T; Hisada T
    Lung Cancer; 2019 Aug; 134():180-186. PubMed ID: 31319979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative identification of clinicopathological prognostic factors for relapse-free survival in clinical N1 non-small cell lung cancer: a retrospective single center-based study.
    Aragaki M; Kato T; Fujiwara-Kuroda A; Hida Y; Kaga K; Wakasa S
    J Cardiothorac Surg; 2020 Aug; 15(1):229. PubMed ID: 32859238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationships between transporter expression and the status of BRAF V600E mutation and F-18 FDG uptake in papillary thyroid carcinomas.
    Yoon M; Jung SJ; Kim TH; Ha TK; Urm SH; Park JS; Lee SM; Bae SK
    Endocr Res; 2016; 41(1):64-9. PubMed ID: 26513490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary tumor standardized uptake value (SUVmax) measured on
    Hui Z; Wei F; Ren H; Xu W; Ren X
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2595-2605. PubMed ID: 32494919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of a novel scoring system using inflammatory response biomarkers in non-small cell lung cancer: A retrospective study.
    Wang Y; Hu X; Xu W; Wang H; Huang Y; Che G
    Thorac Cancer; 2019 Jun; 10(6):1402-1411. PubMed ID: 31104359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
    Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
    Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammation-based prognostic scoring system for predicting the prognosis of advanced small cell lung cancer patients receiving anlotinib monotherapy.
    Chen T; Tang M; Xu X; Liang G; Xiang Z; Lu Y; Wang C; Shen W
    J Clin Lab Anal; 2022 Dec; 36(12):e24772. PubMed ID: 36441595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can we define any marker associated with brain failure in patients with locally advanced non-small cell lung cancer?
    Sert F; Cosgun G; Yalman D; Ozkok S
    Cancer Radiother; 2021 Jun; 25(4):316-322. PubMed ID: 33422415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammation-related parameter serve as prognostic biomarker in esophageal squamous cell carcinoma.
    Xu X; Jing J
    Front Oncol; 2022; 12():900305. PubMed ID: 36338698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of preoperative inflammatory response biomarkers in patients undergoing curative thoracoscopic esophagectomy for esophageal squamous cell carcinoma.
    Hirahara N; Matsubara T; Kawahara D; Nakada S; Ishibashi S; Tajima Y
    Eur J Surg Oncol; 2017 Feb; 43(2):493-501. PubMed ID: 28034501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Importance of Systemic Inflammation Markers in the Survival of Patients with Complicated Colorectal Cancer, Operated in Emergency.
    Constantin GB; Firescu D; Voicu D; Ștefănescu B; Serban RMC; Panaitescu E; Bîrlă R; Constantinoiu S
    Chirurgia (Bucur); 2020; 115(1):39-49. PubMed ID: 32155398
    [No Abstract]   [Full Text] [Related]  

  • 39. The clinical use of pretreatment NLR, PLR, and LMR in patients with esophageal squamous cell carcinoma: evidence from a meta-analysis.
    Sun Y; Zhang L
    Cancer Manag Res; 2018; 10():6167-6179. PubMed ID: 30538564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomography.
    Khandani AH; Dunphy CH; Meteesatien P; Dufault DL; Ivanovic M; Shea TC
    Nucl Med Commun; 2009 Aug; 30(8):594-601. PubMed ID: 19536037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.